Institut für klinische Forschung GmbH

Neu-Isenburg 63263

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma — Completed